Purchases and Sales Made in Q4 2023 in Axsome Therapeutics, Inc. (AXSM)
This table provides information about the institutional ownership of Axsome Therapeutics, Inc. (AXSM) during Q4 2023. The information is specifically focused on institutions that hold shares of Axsome Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 12, 2024
Q4 2023
|
Hsbc Holdings PLC
London, X0 |
SELL
|
- |
-68.4K- 45.95% |
$3.93M - $5.72M
|
80.4K
$8.36M
|
|
|
Feb 14, 2024
Q4 2023
|
Putnam Investments LLC
Boston, MA |
SELL
|
- |
-74.8K- 62.18% |
$4.29M - $6.25M
|
45.5K
$4.73M
|
|
|
Feb 14, 2024
Q4 2023
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-141K- 12.34% |
$8.08M - $11.8M
|
1M
$104M
|
|
|
Feb 14, 2024
Q4 2023
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-150K- 7.04% |
$8.61M - $12.5M
|
1.98M
$206M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-207K- 15.94% |
$11.9M - $17.3M
|
1.09M
$113M
|
|
|
Feb 07, 2024
Q4 2023
|
Nicholas Investment Partners, LP
Rancho Santa Fe, CA |
SELL
|
- |
-312K- 79.08% |
$17.9M - $26.1M
|
82.6K
$8.59M
|